Incidence of cognitively defined late-onset Alzheimer's dementia subgroups from a prospective cohort study
- PMID: 28623677
- PMCID: PMC5723557
- DOI: 10.1016/j.jalz.2017.04.011
Incidence of cognitively defined late-onset Alzheimer's dementia subgroups from a prospective cohort study
Abstract
Introduction: There may be biologically relevant heterogeneity within typical late-onset Alzheimer's dementia.
Methods: We analyzed cognitive data from people with incident late-onset Alzheimer's dementia from a prospective cohort study. We determined individual averages across memory, visuospatial functioning, language, and executive functioning. We identified domains with substantial impairments relative to that average. We compared demographic, neuropathology, and genetic findings across groups defined by relative impairments.
Results: During 32,286 person-years of follow-up, 869 people developed Alzheimer's dementia. There were 393 (48%) with no domain with substantial relative impairments. Some participants had isolated relative impairments in memory (148, 18%), visuospatial functioning (117, 14%), language (71, 9%), and executive functioning (66, 8%). The group with isolated relative memory impairments had higher proportions with ≥ APOE ε4 allele, more extensive Alzheimer's-related neuropathology, and higher proportions with other Alzheimer's dementia genetic risk variants.
Discussion: A cognitive subgrouping strategy may identify biologically distinct subsets of people with Alzheimer's dementia.
Keywords: Alzheimer's disease; Cognition; Endophenotypes; Genetics; Heterogeneity; Neuropathology; Subgroups.
Copyright © 2017 the Alzheimer's Association. All rights reserved.
References
-
- Gotovac K, Hajnsek S, Pasic MB, Pivac N, Borovecki F. Personalized medicine in neurodegenerative diseases: how far away? Mol Diagn Ther. 2014;18(1):17–24. - PubMed
-
- Kosik KS. Personalized medicine for effective Alzheimer disease treatment. JAMA Neurol. 2015;72(5):497–498. - PubMed
-
- Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614–629. - PubMed
-
- Lezak MD. Neuropsychological assessment. 3. NY: Oxford University Press; 1995.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous